Ipamorelin

Prime Peptide is the only Bulgarian brand that, in addition to the standard LC-MS/MS purity analysis, also conducts additional independent tests for sterility and endotoxin levels – three key quality indicators, providing the highest standard of laboratory control.

Copies of the laboratory certificates can be found in the product images, at the end of the description of each product or in the "Certificates" section. Each certificate contains a unique number and password, through which you can verify its authenticity directly in the database of the Polish laboratory Analiza Bialek

What is Ipamorelin?

Ipamorelin is a synthetic peptide from the GHRP (growth hormone releasing peptides) group that stimulates the natural release of growth hormone (GH) from the pituitary gland. It acts by activating the ghrelin receptors (GHS-R), which are involved in regulating growth hormone secretion.

Ipamorelin was developed in the 1990s as a more selective alternative to earlier peptides from the same group such as GHRP-2 and GHRP-6. The main goal of its development was to create a molecule that stimulates growth hormone release without causing significant increases in other hormones like cortisol, prolactin or adrenocorticotropic hormone. For this reason, Ipamorelin is often described as one of the most selective peptides for stimulating growth hormone.

The peptide mimics the action of the natural hormone ghrelin – a signaling molecule that plays a role in regulating appetite, energy balance and growth hormone release. When Ipamorelin binds to ghrelin receptors, it sends a signal to the pituitary gland to release growth hormone via a mechanism close to the body’s natural physiological processes.

One interesting fact about Ipamorelin is that it stimulates growth hormone without a significant effect on appetite, an effect often seen with other peptides from the same group. This makes it particularly interesting in research related to metabolism, recovery and regulation of hormonal balance.

What are the benefits of Ipamorelin?

Based on scientific research, Ipamorelin is considered a peptide with potential significance for stimulating growth hormone and recovery processes in the body.

• Stimulation of natural growth hormone release

Ipamorelin stimulates the pituitary gland to release growth hormone via a natural mechanism by activating ghrelin receptors.

• Support for tissue recovery

Growth hormone plays a key role in tissue regeneration processes, making this peptide a subject of interest in research related to the recovery of muscles, tendons and other tissues.

• Support for muscle growth

Some studies examine its potential role in supporting muscle mass by stimulating growth hormone and IGF-1.

• Improvement of metabolism

Growth hormone is involved in regulating fat metabolism and energy balance, which makes Ipamorelin of interest in studies related to body composition.

• Interest in anti-aging research

Since growth hormone levels naturally decline with age, Ipamorelin is also being investigated in the context of aging processes and cellular recovery.

• More selective action compared to other GHRP peptides

Unlike some other peptides from the same group, Ipamorelin shows more selective action on growth hormone and less influence on other hormonal systems.

Clinical trials on Ipamorelin

Ipamorelin has been the subject of a number of scientific studies aimed at understanding its effect on growth hormone secretion.

In experimental studies it has been observed that the peptide stimulates the release of growth hormone from the pituitary gland by activating ghrelin receptors. These studies show that Ipamorelin can increase GH levels without significant effects on cortisol and prolactin.

Some scientific publications examine its potential role in studies related to metabolism, tissue recovery and regulation of hormonal balance.

Due to this selectivity, Ipamorelin remains an important molecule in research related to growth hormone, metabolism and recovery processes.

Proper administration and dosage of Ipamorelin

Ipamorelin is typically administered via subcutaneous injection. Exact dosage may vary depending on specific goals and the research protocol used.

In scientific studies commonly used doses are:

200 – 300 mcg subcutaneously, 1 – 2 times daily for a period of 8 – 12 weeks.

In many studies the peptide is combined with GHRH analogs such as CJC-1295 or Sermorelin, as the combination can lead to a stronger physiological stimulus for growth hormone release.

Duration of use may vary depending on the goals of the study and the application regimen used.

Possible side effects of Ipamorelin

As with many bioactive peptides, some adverse reactions may be observed when using Ipamorelin.

Most common side effects

• mild redness at the injection site
• headache
• temporary fatigue

Less common reactions

• mild nausea
• dizziness

In most cases these reactions are mild and short-lived, especially when recommended dosages are followed.

Comparison of Ipamorelin with other peptides

Ipamorelin belongs to the group of GHRP secretagogues, which means it stimulates growth hormone release by activating ghrelin receptors (GHS-R1a). This places it in a clear category compared to peptides that act via the GHRH mechanism or directly deliver the hormone.

Ipamorelin vs hGH (Somatotropin)
hGH (Somatotropin) is a direct exogenous growth hormone that enters the body ready-made and bypasses natural regulation. Ipamorelin, on the other hand, does not deliver hormone from outside, but stimulates the pituitary gland to release its own GH. The difference is fundamental: with hGH there is an external hormone, with Ipamorelin there is activation of the body's own GH axis.

Ipamorelin vs Sermorelin
Sermorelin is a GHRH analog and stimulates GH via GHRH receptors in the pituitary gland. Ipamorelin works by a different mechanism through ghrelin receptors. These are two parallel pathways for GH stimulation, which is why they are often combined for a stronger and more physiological effect.

Ipamorelin vs GHRP-2 and GHRP-6
GHRP-2 and GHRP-6 are also GHRP secretagogues and act through the same receptor mechanism. The difference is in the profile. They usually lead to a stronger and faster GH peak, but are associated with increased appetite and a more pronounced effect on cortisol and prolactin. Ipamorelin is significantly more selective and provides a cleaner GH signal without unnecessary side effects.

Ipamorelin vs CJC-1295 without DAC
CJC-1295 without DAC is a GHRH analog that stimulates GH via a different receptor pathway. Ipamorelin acts through GHS-R receptors, which makes it complementary rather than competitive. The combination of the two leads to a fuller and more natural GH response.

Ipamorelin vs CJC-1295 with DAC
CJC-1295 with DAC is a long-acting GHRH analog where DAC (Drug Affinity Complex) allows binding to plasma proteins and maintenance of activity for days. Ipamorelin is short-acting and works in a pulsatile pattern, closer to natural GH release. The difference is that CJC with DAC provides continuous stimulation, while Ipamorelin provides controlled and physiological peaks.

Ipamorelin vs Tesamorelin
Tesamorelin is a stronger and more stable GHRH analog that leads to a more pronounced increase in GH and IGF-1. Ipamorelin, as a GHRP peptide, works by a different mechanism and is characterized by a milder and more controlled profile. Tesamorelin gives a more intense effect, while Ipamorelin offers a better balance and lower risk of side effects.

The information on this website has been collected and summarized from numerous scientific studies and analyses.

It is purely informational and is not intended for diagnosing, treating, or preventing diseases.

The products offered on the site are not classified as medicines or medical devices and are intended only for laboratory and scientific research purposes.

Verify the authenticity of this certificate via the official website of the independent laboratory Analiza Bialek.

Verify the authenticity of this certificate via the official website of the independent laboratory Analiza Bialek.